303 related articles for article (PubMed ID: 18519766)
1. HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma.
Han LY; Fletcher MS; Urbauer DL; Mueller P; Landen CN; Kamat AA; Lin YG; Merritt WM; Spannuth WA; Deavers MT; De Geest K; Gershenson DM; Lutgendorf SK; Ferrone S; Sood AK
Clin Cancer Res; 2008 Jun; 14(11):3372-9. PubMed ID: 18519766
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S
Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726
[TBL] [Abstract][Full Text] [Related]
3. Expression of antigen processing and presenting molecules in brain metastasis of breast cancer.
Liu Y; Komohara Y; Domenick N; Ohno M; Ikeura M; Hamilton RL; Horbinski C; Wang X; Ferrone S; Okada H
Cancer Immunol Immunother; 2012 Jun; 61(6):789-801. PubMed ID: 22065046
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.
Facoetti A; Nano R; Zelini P; Morbini P; Benericetti E; Ceroni M; Campoli M; Ferrone S
Clin Cancer Res; 2005 Dec; 11(23):8304-11. PubMed ID: 16322289
[TBL] [Abstract][Full Text] [Related]
5. Association of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer.
Ayshamgul H; Ma H; Ilyar S; Zhang LW; Abulizi A
Chin Med J (Engl); 2011 Feb; 124(3):341-6. PubMed ID: 21362330
[TBL] [Abstract][Full Text] [Related]
6. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.
Mehta AM; Jordanova ES; Kenter GG; Ferrone S; Fleuren GJ
Cancer Immunol Immunother; 2008 Feb; 57(2):197-206. PubMed ID: 17622526
[TBL] [Abstract][Full Text] [Related]
7. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
[TBL] [Abstract][Full Text] [Related]
8. HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis.
Bandoh N; Ogino T; Katayama A; Takahara M; Katada A; Hayashi T; Harabuchi Y
Oncol Rep; 2010 Apr; 23(4):933-9. PubMed ID: 20204276
[TBL] [Abstract][Full Text] [Related]
9. HLA class I is most tightly linked to levels of tapasin compared with other antigen-processing proteins in glioblastoma.
Thuring C; Follin E; Geironson L; Freyhult E; Junghans V; Harndahl M; Buus S; Paulsson KM
Br J Cancer; 2015 Sep; 113(6):952-62. PubMed ID: 26313662
[TBL] [Abstract][Full Text] [Related]
10. Expression of transporters associated with antigen processing and human leucocyte antigen class I in malignant melanoma and its association with prognostic factors.
Tao J; Li Y; Liu YQ; Li L; Liu J; Shen X; Shen GX; Tu YT
Br J Dermatol; 2008 Jan; 158(1):88-94. PubMed ID: 17999701
[TBL] [Abstract][Full Text] [Related]
11. The prognostic impact of human leukocyte antigen (HLA) class I antigen abnormalities in salivary gland cancer. A clinicopathological study of 288 cases.
Müller M; Agaimy A; Zenk J; Ettl T; Iro H; Hartmann A; Seliger B; Schwarz S
Histopathology; 2013 May; 62(6):847-59. PubMed ID: 23611358
[TBL] [Abstract][Full Text] [Related]
12. MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.
Garcia-Lora A; Martinez M; Algarra I; Gaforio JJ; Garrido F
Int J Cancer; 2003 Sep; 106(4):521-527. PubMed ID: 12845647
[TBL] [Abstract][Full Text] [Related]
13. WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?
Mehling M; Simon P; Mittelbronn M; Meyermann R; Ferrone S; Weller M; Wiendl H
Acta Neuropathol; 2007 Aug; 114(2):111-9. PubMed ID: 17541610
[TBL] [Abstract][Full Text] [Related]
14. HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.
Vitale M; Pelusi G; Taroni B; Gobbi G; Micheloni C; Rezzani R; Donato F; Wang X; Ferrone S
Clin Cancer Res; 2005 Jan; 11(1):67-72. PubMed ID: 15671529
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B
J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847
[TBL] [Abstract][Full Text] [Related]
16. Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients.
Lazaridou MF; Gonschorek E; Massa C; Friedrich M; Handke D; Mueller A; Jasinski-Bergner S; Dummer R; Koelblinger P; Seliger B
Oncoimmunology; 2020 Jun; 9(1):1774323. PubMed ID: 32923135
[TBL] [Abstract][Full Text] [Related]
17. [Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in laryngeal squamous cell carcinoma].
Zeng Q; Wang XL; Xu ZG; Lü N; Zheng S; Zhao QZ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):234-40. PubMed ID: 22805026
[TBL] [Abstract][Full Text] [Related]
18. Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients.
Ogino T; Bandoh N; Hayashi T; Miyokawa N; Harabuchi Y; Ferrone S
Clin Cancer Res; 2003 Sep; 9(11):4043-51. PubMed ID: 14519625
[TBL] [Abstract][Full Text] [Related]
19. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
[TBL] [Abstract][Full Text] [Related]
20. Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer.
Seliger B; Stoehr R; Handke D; Mueller A; Ferrone S; Wullich B; Tannapfel A; Hofstaedter F; Hartmann A
Cancer Immunol Immunother; 2010 Apr; 59(4):529-40. PubMed ID: 19820934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
